Financial Performance - The company's operating revenue for Q1 2022 was ¥98,027,811.38, representing a year-on-year increase of 33.94%[5]. - The net profit attributable to shareholders was a loss of ¥27,858,515.60, with a year-on-year decrease of ¥7,689,251.04 due to increased personnel costs[5][8]. - The company reported a net loss of RMB 218,061,171.66, compared to a loss of RMB 190,202,656.06 in the previous year[16]. - The net profit attributable to the parent company was -27,858,515.60 CNY, compared to -20,169,264.57 CNY in the same period last year, reflecting a decline of approximately 38.5%[19]. - The company’s operating profit was -45,205,360.05 CNY, worsening from -30,267,249.92 CNY in the same quarter last year, indicating a decline of approximately 49.5%[18]. - The company reported a total comprehensive income of -37,033,436.97 CNY, compared to -24,924,223.17 CNY in the same quarter last year, marking an increase in losses of about 48.8%[19]. - The company's basic and diluted earnings per share were both -0.20 CNY, unchanged from the previous year[19]. Research and Development - Research and development (R&D) expenses totaled ¥52,032,614.41, which is an increase of 72.57% compared to the previous year, accounting for 53.08% of operating revenue, up by 11.88 percentage points[6][8]. - The company experienced a significant increase in R&D personnel, contributing to higher R&D costs[8]. - Research and development expenses rose to 48,010,998.55 CNY, up from 30,151,889.52 CNY, indicating a growth of approximately 59.4%[18]. Cash Flow and Assets - The net cash flow from operating activities was a negative ¥157,222,315.08, indicating challenges in cash collection from clients[6][8]. - The net cash flow from operating activities was -157,222,315.08 CNY, worsening from -93,764,377.91 CNY in the previous year[22]. - Cash and cash equivalents decreased to RMB 894,427,940.60 from RMB 1,273,521,765.55, representing a decline of approximately 30% year-over-year[14]. - The cash and cash equivalents at the end of the period were 832,554,512.54 CNY, down from 1,209,148,322.49 CNY at the beginning of the period, a decrease of approximately 31.1%[23]. - Total assets at the end of the reporting period were ¥2,230,348,720.37, down 8.77% from the end of the previous year[6]. - The company's total assets were RMB 2,230,348,720.37, down from RMB 2,444,869,042.34, showing a decrease of around 9%[16]. - Total current assets amounted to RMB 2,025,025,787.00, down from RMB 2,269,015,610.12, indicating a decrease of about 11%[14]. - Total liabilities decreased to RMB 472,779,794.24 from RMB 650,266,679.24, a reduction of about 27%[16]. - The total equity attributable to shareholders decreased to RMB 1,707,097,771.52 from RMB 1,734,956,287.12, a decline of about 2%[16]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,726[10]. - The top shareholder, Xia Jun, holds 17.91% of the shares, totaling 24,690,198 shares[10][11]. Operating Costs - The total operating costs increased to 150,663,048.75 CNY from 106,343,310.91 CNY, representing an increase of about 41.7% year-over-year[18]. - The company incurred a financial expense of -2,007,438.46 CNY, compared to a financial income of 750,564.06 CNY in the previous year, indicating a significant shift in financial performance[18]. Sales Performance - The total revenue from sales of goods and services was 105,143,461.21 CNY, an increase from 99,973,624.84 CNY year-over-year, reflecting a growth of about 5.2%[21]. Market and Product Development - The company has not disclosed any new product developments or market expansion strategies in the current report[13].
嘉和美康(688246) - 2022 Q1 - 季度财报